Schizophrenia Trials in atlanta, united states
Conditions / Schizophrenia / atlanta, united states
Schizophrenia is a medical condition with active clinical research programs worldwide.
191 total trials for this combination
Showing top 10 of 191 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00731549 | Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia | COMPLETED | PHASE3 |
| NCT01432444 | Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole | COMPLETED | PHASE3 |
| NCT05304767 | An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia | RECRUITING | PHASE3 |
| NCT05211947 | A Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX Study | TERMINATED | PHASE3 |
| NCT01714713 | A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy | COMPLETED | PHASE3 |
| NCT05145413 | A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia | COMPLETED | PHASE3 |
| NCT00528905 | Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia | COMPLETED | PHASE2 |
| NCT00396214 | Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients | TERMINATED | PHASE3 |
| NCT01714661 | Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy | COMPLETED | PHASE3 |
| NCT03345342 | A Study of Paliperidone Palmitate 6-Month Formulation | COMPLETED | PHASE3 |